Written by
Divyansh Mangal
Raksheet Jain
Introduction
For Divyansh Mangal and Raksheet Jain, co-founders of Aignosis, the challenges of autism diagnosis in India were deeply personal. The lengthy and inefficient process of diagnosing autism motivated them to build a solution that could transform child development and healthcare in India. This blog explores their journey, achievements, and vision for revolutionizing early autism diagnosis in the country.
The Problem: A Lengthy and Complex Process
The existing autism diagnosis process is fraught with challenges. Long waiting times—often stretching to four or five weeks—and the requirement of dedicating an entire day for an accurate diagnosis have made the process burdensome for families. These delays can have significant consequences, as early intervention is crucial for children with autism to reach their full potential. Recognizing this critical gap, Divyansh and Raksheet set out to create a solution that would redefine the way autism is diagnosed.
The Vision: Accessible and Efficient Autism Screening
The vision of Aignosis was clear from the start: to develop a tool that could efficiently screen for autism and make it accessible at all pediatric centers. This mission was not just about convenience; it was about ensuring that every child, regardless of their location, had access to early and accurate autism detection.
Building the Solution: Collaboration and Expertise
To bring their vision to life, the co-founders collaborated with leading experts from ICAD and Dr. Dhananajay Mangal, whose insights were instrumental in shaping the tool's features. Combining this expertise with their technological know-how, they developed a screening tool designed to transform the diagnostic landscape. Mentorship and guidance from industry leaders like Mr. Rajneesh Bhandari and Amit Jain, CEO of Car Dekho Group, further propelled their journey, refining their product and strategy.
Validation Through Clinical Studies
One of the most significant milestones for Aignosis was the successful completion of a clinical study involving over 390 students. The tool achieved a remarkable 95% accuracy rate, a testament to its potential to revolutionize autism diagnosis. This validation was not just a technical achievement; it was a moment of hope for countless families across India.
The Shark Tank Experience: A Turning Point
As lifelong fans of Shark Tank, Divyansh and Raksheet saw an opportunity to take their mission to the next level by participating in Season 4 of the show. Their journey to the Shark Tank stage was fueled by determination and a belief in their vision. The exposure and momentum gained from this experience marked a pivotal moment for Aignosis, positioning the startup as a leader in the field of child development technology.
Looking Ahead: Transforming Child Development in India
With initial funding, clinical validation, and the support of mentors and institutions, Aignosis is now poised to scale its impact. The startup's goal is to make early autism detection a reality for every child in India, ensuring that no family has to endure unnecessary delays in seeking the care their child needs.
Conclusion
Aignosis is more than just a technological innovation; it is a beacon of hope for families navigating the challenges of autism diagnosis. Driven by the shared passion of its founders and supported by a robust network of experts and institutions, Aignosis is set to transform child development in India. By making early autism screening accessible and efficient, Aignosis is not just filling a gap—it is creating a future where every child can thrive.
Not sure whether to wait or check?
A ten-minute video session gives you an objective read on your child's development — no appointment, no waiting room.